Open Access Article
This Open Access Article is licensed under a Creative Commons Attribution 3.0 Unported Licence
Correction: Virtual screening and optimization of Type II inhibitors of JAK2 from a natural product library
Dik-Lung
Ma
*a,
Daniel Shiu-Hin
Chan
a,
Guo
Wei
b,
Hai-Jing
Zhong
c,
Hui
Yang
a,
Lai To
Leung
b,
Elizabeth A.
Gullen
d,
Pauline
Chiu
*b,
Yung-Chi
Cheng
*d and
Chung-Hang
Leung
*c
aDepartment of Chemistry, Hong Kong Baptist University, Kowloon Tong, Hong Kong, China. E-mail: edmondma@hkbu.edu.hk
bDepartment of Chemistry and the State Key Laboratory of Synthetic Chemistry, The University of Hong Kong, Pokfulam Road, Hong Kong, China. E-mail: pchiu@hku.hk
cState Key Laboratory of Quality Research in Chinese Medicine, Institute of Chinese Medical Sciences, University of Macau, Macao, China. E-mail: duncanleung@umac.mo
dDepartment of Pharmacology, Yale University School of Medicine, New Haven, CT 06520, USA. E-mail: yccheng@yale.edu
First published on 27th November 2014
Abstract
Correction for ‘Virtual screening and optimization of Type II inhibitors of JAK2 from a natural product library’ by Dik-Lung Ma et al., Chem. Commun., 2014, 50, 13885–13888.
We regret that funding information was omitted from the original manuscript by the Editorial Office. The acknowledgements should read as follows:
This work is supported by Hong Kong Baptist University (FRG2/13-14/008), Centre for Cancer and Inflammation Research, School of Chinese Medicine (CCIR-SCM, HKBU), the Health and Medical Research Fund (HMRF/11101212 and HMRF/13121482), the Research Grants Council (HKBU/201811, HKBU/204612 and HKBU/201913), the French National Research Agency/Research Grants Council Joint Research Scheme (A-HKBU201/12), the State Key Laboratory of Synthetic Chemistry, the Science and Technology Development Fund, Macao SAR (103/2012/A3) and the University of Macau (MYRG091(Y3-L2)-ICMS12-LCH, MYRG121(Y3-L2)-ICMS12-LCH, MRG007/LCH/2014/ICMS and MRG023/LCH/2013/ICMS), National Cancer Institute (PO1CA154295-04) and National Institutes of Health (AI38204). Yung-Chi Cheng is a fellow of the National Foundation for Cancer Research. We especially thank Novartis Pharma AG for providing NVP-BBT594 for the biological assays.
The Royal Society of Chemistry apologises for these errors and any consequent inconvenience to authors and readers.
| This journal is © The Royal Society of Chemistry 2015 |